Successful TB-HIV programme in Myanmar receives $ 4 million from Yadana Consortium operated by Total E&P Myanmar





15 December -- In 2005, when The Union and Myanmar's Ministry of Health agreed to launch a pilot project offering integrated TB-HIV care through the public health services, the Yadana Consortium operated by Total E&P Myanmar offered $200,000 in first-year funding to provide antiretroviral therapy for 150 patients. The Consortium has since increased its grant several times; and Yadana has now committed US$ 4million to fund the successful programme from 2010 to 2014. This will provide antiretroviral therapy for 2,000 patients over the next 5 years.

The Integrated HIV Care for TB Patients Living with HIV/AIDS (IHC) Programme initially began in 5 townships of Mandalay. Under the direction of Dr Philippe Clevenbergh of The Union's Department of HIV, it has grown steadily and now covers a population of approximately 1.5 million people in the 7 townships of Mandalay and in Pakokku municipality. The program is a pioneer collaboration between the public health sector, an international NGO and the private sector in Myanmar.

The IHC programme today provides comprehensive and integrated HIV care, including antiretroviral therapy, to TB patients co-infected with HIV, as well as their HIV-positive relatives. The coalition of stakeholders involved in the programme includes not only the national TB and AIDS programmes, but also township health centres, hospitals, laboratories, social workers, self-help groups and people living with HIV.

In 2008, the Global Business Coalition on AIDS, TB and Malaria honoured the programme, saying it “excels in its multi-sector approach, full integration of HIV and TB, and focus on long-term sustainability through local capacity building”.

Highlights of the programme's achievements as of October 2009 include:
- About 75% of adult TB patients in Mandalay and Pakokku have received HIV tests through the program.
- More than 3,000 people have been enrolled in a comprehensive package of care.
- More than 2,300 patients have been on ART in 5 years of implementation, and of these 1,879 were alive at the end of 2008.

“The IHC Programme in Myanmar offers a model for managing the TB-HIV co-epidemics that can show the way for other countries facing the same challenges with limited resources”, says Dr Nils E Billo, Executive Director of The Union.

About The Union
The International Union Against Tuberculosis and Lung Disease (The Union) is an international scientific organisation that brings innovation, expertise, solutions and support to address health challenges in low- and middle-income populations. Based in Paris with offices serving Africa, Asia, Europe, Latin America, the Middle East and North America, The Union has close to 10,000 members and subscribers from 152 countries. Its scientific departments focus on tuberculosis, HIV, lung health and non-communicable diseases, tobacco control and research.

To learn more about The Union, please visit www.theunion.org.